dobutamine has been researched along with milrinone in 197 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (11.68) | 18.7374 |
| 1990's | 34 (17.26) | 18.2507 |
| 2000's | 66 (33.50) | 29.6817 |
| 2010's | 45 (22.84) | 24.3611 |
| 2020's | 29 (14.72) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A | 1 |
| Gerdesmeyer, L; Herrmann, G; Meissner, A; Simon, R | 1 |
| Berdeaux, A; Gérard, JL; Giudicelli, JF; Gosgnach, M | 1 |
| Costa, R; De Marino, V; Marino, A | 1 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G | 1 |
| Abe, Y; Kitada, Y; Narimatsu, A; Tobe, A | 1 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Drexler, H; Löllgen, H | 1 |
| Kobayashi, K; Matsumoto, A; Tajimi, K; Tanaka, H | 1 |
| Brown, L; Erdmann, E; Lorenz, B | 1 |
| Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
| Drexler, H; Faude, F; Höing, S; Just, H; Wollschläger, H | 1 |
| Hood, WB; Imai, N; Kawashima, S; Liang, CS; Stone, CK; Thomas, A | 1 |
| Porsius, AJ; van der Wouw, PA; van Rooij, HH; Vleeming, W; Wemer, J | 1 |
| Berdeaux, A; Gerard, JL; Giudicelli, JF | 1 |
| Colucci, WS; Denniss, AR; Gauthier, DF; Leatherman, GF; Ludmer, PL; Marsh, JD; Quigg, RJ | 1 |
| Andersson, KE | 1 |
| Dhainaut, JF | 1 |
| Colucci, WS | 2 |
| Leier, CV | 1 |
| LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
| Ruggie, N | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| Baim, DS; Lanoue, AS; Monrad, ES; Smith, HS | 1 |
| Braunwald, E; Colucci, WS; Fifer, MA; Jaski, BE; Wright, RF | 1 |
| Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L | 1 |
| Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS | 1 |
| Ferguson, JJ; Grossman, W; McKay, RG; Miller, MJ; Momomura, S; Pasternak, RC; Sahagian, P | 1 |
| Borow, KM; Lang, RM; Neumann, A | 1 |
| Greenberg, M; Grose, R; LeJemtel, TH; Strain, J | 1 |
| Alonso Francia, C; Calvo Cebollero, I; Diarte de Miguel, JA; Gomollón García, JP; Placer Peralta, LJ | 1 |
| Cody, RJ; Konstam, MA | 1 |
| Frohlich, ED; McFadden, PM; Ochsner, JL; Pridjian, AK; VanMeter, CH | 1 |
| Domínguez de Rozas, JM; Guindo Soldevila, J; Martínez Vílchez, R; Rodríguez Font, E | 1 |
| Amsterdam, EA; Rendig, SV | 1 |
| Chung, KC; McFadden, PM; Ochsner, JL; Pridjian, AK; Touchard, CL; VanMeter, CH | 1 |
| Stanek, EJ | 1 |
| Clark, WA; Denes, P; Fernandez, RN; Heaney, L; Marius-Nunez, AL; Ranganini, A; Silber, E | 1 |
| Berk, MR; DeMaria, AN; DeWood, MA; Karlsberg, RP; Lasher, KP | 1 |
| Meissner, A; Schmelzle, T; Simon, R | 1 |
| Asai, K; Kudej, RK; Patrick, T; Sato, N; Uechi, M; Vatner, SF | 1 |
| Erdmann, E | 1 |
| Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D | 1 |
| Harjai, KJ; Lapeyre, YM; Mehra, MR; Murgo, JP; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Heyman, S; Ozdemir, S; Zucker, I | 1 |
| Bellomo, R; Cole, L; Ronco, C | 1 |
| Maisel, A; Nuñez, S | 1 |
| McCloskey, WW | 1 |
| Hata, H; Kimura, S; Obana, M; Ohmiya, S; Orime, Y; Sezai, A; Sezai, Y; Shiono, M; Tsukamoto, S; Yagi, S; Yamada, H | 1 |
| Hata, H; Hata, M; Kimura, S; Obana, M; Okumura, H; Orime, Y; Sezai, A; Sezai, Y; Shiono, M; Tsukamoto, S; Yagi, S | 1 |
| Liu, L; Zhao, SP | 1 |
| Fujihara, H; Fukuda, S; Kurokawa, S; Shimoji, K; Tobita, T | 1 |
| Silver, MA | 1 |
| Hisamatsu, Y; Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Ohkusa, T; Ono, K; Tanigawa, T; Ueyama, T; Yamamoto, T; Yano, M | 1 |
| Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P | 1 |
| Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Mochizuki, M; Ohkusa, T; Ono, K; Tanigawa, T; Yamada, J; Yano, M | 1 |
| Moen, EK; Young, JB | 1 |
| Cohen, AJ; Ezra, S; Jackobshvilli, S; Medalion, B; Schachner, A; Zabeeda, D | 1 |
| Feneck, RO; Oduro-Dominah, A; Sherry, KM; Withington, PS | 1 |
| Birnbaum, Y; Blanche, C; Cercek, B; Dhar, SC; Friedman, A; Hayes, S; Naqvi, T; Siegel, RJ; Trento, A | 1 |
| Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T | 1 |
| Gorski, LA | 1 |
| Ewald, G; Mindel, G; Saab, G; Vijayan, A | 1 |
| Karasawa, F; Okuda, T; Takamatsu, I | 1 |
| Aramaki, Y; Takase, K; Uechi, M | 1 |
| Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM | 1 |
| Felker, GM; O'connor, CM | 1 |
| Aranda, JM; Cleeton, TS; Hill, JA; Leach, D; Lopez, LM; Monroe, VS; Pauly, DF; Schofield, RS; Walker, TC | 1 |
| Edwards, N; Hankins, S; Hauff, H; Lang, CC; Mancini, DM; Maybaum, S | 1 |
| Chatterjee, K; De Marco, T | 1 |
| Aranda, JM; Hill, JA; Hsu, K; Pauly, DF; Schofield, R | 1 |
| Carron, C; Gibbons, W; López-Candales, A; Schwartz, J; Simmons, P; Vora, T | 1 |
| Carron, C; López-Candales, AL; Schwartz, J | 1 |
| Aranda, JM; Hill, JA; Pauly, DF; Rodriguez, E; Schofield, RS; Woo, G | 1 |
| Kaplinsky, EJ; Manito, N; Pujol, R | 1 |
| Katz, SD; Lee, FA; Nystrom, K; Saldarriaga, C; Sedrakyan, A; Upadya, S; Verma, S | 1 |
| Sharma, M; Teerlink, JR | 1 |
| Mochizuki, M; Nishimura, R; Sasaki, N; Takao, K; Tobata, D | 1 |
| Commichau, C; Connolly, ES; Du, Y; Fitzsimmons, BF; Kreiter, KT; Lavine, SD; Mayer, SA; Naidech, A; Parra, A | 1 |
| Bornstein, SR; Fournell, A; Picker, O; Scheeren, TW; Schwarte, LA | 1 |
| Coopersmith, CM | 1 |
| Hébert, TE; Rohlicek, CV; Trieu, P; Viau, S | 1 |
| Noori, S; Seri, I | 2 |
| Osborn, DA | 1 |
| Dean, AS; Gaughan, JP; Libonati, JR; Margulies, KB; Nicholas, JJ; Rubin, S | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Bayram, M; De Luca, L; Gheorghiade, M; Massie, MB | 1 |
| Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G | 1 |
| Ebisawa, T; Fujimoto, K; Hori, Y; Maekawa, S; Uechi, M; Yamano, S | 1 |
| Arnold, LM; Carroll, NV; Crouch, MA; Oinonen, MJ | 1 |
| Barber, BJ; Benson, DW; Cripe, LH; Markham, LW; Spicer, RL; Weidner, N; Wong, BL | 1 |
| Kirby, DS; Lobato, EB; Muehlschlegel, JD; Sidi, A | 1 |
| Kurien, S; Miller, WL; Warfield, KT; Wood, CM | 1 |
| George, A; Hauptman, PJ; Hoover, R; Mikolajczak, P; Mohr, CJ; Schnitzler, MA; Swindle, J | 1 |
| Pagel, PS | 1 |
| Cromheecke, S; De Hert, SG; Lorsomradee, S; Van der Linden, PJ | 1 |
| Barraud, D; Damy, T; Faivre, V; Gayat, E; Heymes, C; Mebazaa, A; Payen, D; Shah, AM; Welschbillig, S | 1 |
| Angus, JA; Rohrlach, R; Royse, AG; Royse, CF; Wright, CE | 1 |
| Berg, AM; Mahle, WT; Snell, L | 1 |
| Farmakis, D; Nieminen, M; Parissis, JT | 1 |
| Aranda, JM; Braith, RW; Hill, JA; Klodell, CT; Nichols, WW; Pauly, DF; Pierce, GL; Schofield, RS | 1 |
| Kajimoto, K; Kawana, M; Watanabe, H | 1 |
| Barold, SS; Cutro, R; Dewhurst, R; Herweg, B; Ilercil, A; Krishnan, S; Weston, M | 1 |
| Askovich, B; Berry, JG; Cowley, CG; Hawkins, JA; Shaddy, RE | 1 |
| Banfor, PN; Campbell, TJ; Cox, BF; Fryer, RM; Marsh, KC; Polakowski, JS; Preusser, LC; Reinhart, GA | 1 |
| Fryer, RM; Marsh, KC; Polakowski, JS; Segreti, JA | 1 |
| Borsini, F; Carminati, P; Gagnol, JP; Loi, FM; Mattera, GG; Vanoli, E | 1 |
| Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E | 1 |
| Baumert, JH; Hein, M; Roehl, AB; Rossaint, R; Scherer, K; Steendijk, P | 1 |
| Ahmed, I; House, CM; Nelson, WB | 1 |
| Ackermann, D; Grottke, O; Hein, M; Rieg, AD; Rossaint, R; Schälte, G; Schroth, SC | 1 |
| Asamoto, M; Kitamura, T; Mori, Y; Muroya, M; Ohno, N; Sato, K; Yamada, Y | 1 |
| Adachi, H; Ino, T; Kimura, C; Kobinata, T; Naito, K; Okamura, H; Tanaka, M; Yamaguchi, A | 1 |
| Chu, EC; Gorodeski, EZ; Hsich, E; Reese, JR; Shishehbor, MH; Starling, RC | 1 |
| Kato, M; Kitakaze, M; Sanada, S | 1 |
| Rosen, MJ; Sarkar, P; Talwar, A | 1 |
| Bigam, DL; Charrois, G; Cheung, PY; Jewell, LD; Joynt, C; Korbutt, G | 1 |
| Alexander, PM; Butt, WW; Penny, DJ; Ryerson, LM; Shann, FA; Shekerdemian, LS | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Montalto, M | 1 |
| Läer, S; Vogt, W | 2 |
| Jovicić, B; Kosutić, J; Nikolić, L; Prijić, S; Rakić, S; Stajević, M; Vukomanović, V | 1 |
| Fournell, A; Picker, O; Scheeren, TW; Schwarte, LA | 1 |
| Hirayama, A; Kato, M | 1 |
| Brevis Nuñez, F; Chapot, R; Dohna-Schwake, C; Felderhoff-Mueser, U; Neudorf, U; Tschiedel, E | 1 |
| Bøtker, HE; Colding, PD; Hyldebrandt, JA; Kolstrup, LM; Ravn, HB; Schmidt, MR | 1 |
| Chang, CM; Chi, CY; Hung, NT; Khanh, TH; Lin, CC; Liu, CC; Su, IJ; Thinh, le Q; Thoa, le PK; Thuong, TC; Tseng, FC; Wang, JR; Wang, SM; Wu, HC | 1 |
| C Marboe, C; Mancini, D; Sugiyama Kato, T; Yoshizawa, S | 1 |
| Barrett, NA; Berry, WT; Hewson, RW; Langrish, CJ; McKenzie, CA | 1 |
| Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Ravn, HB; Redington, AN; Rothmann, S; Schmidt, MR | 1 |
| Christensen, M; Connolly, S; Goday, PS; Manzi, J; Mikhailov, TA; Panchal, AK; Wakeham, M | 1 |
| Boddu, SH; Churchwell, MD; Howard, MS; Mauro, VF | 1 |
| McNeilly, RG | 1 |
| Coons, JC; Jentzer, JC; Link, CB; Schmidhofer, M | 1 |
| Calabrò, MG; Covello, RD; Greco, M; Greco, T; Landoni, G; Morelli, A; Pasin, L; Zangrillo, A | 1 |
| Burkhardt, BE; Rücker, G; Stiller, B | 1 |
| Mittal, M; Radhakrishnan, M; UmamaheswaraRao, GS | 1 |
| Lim, SY; Morishita, K; Morita, T; Nakamura, K; Ohta, H; Osuga, T; Takiguchi, M; Yokoyama, N | 1 |
| Acharya, D; Hashim, T; Loyaga-Rendon, RY; Morgan, CJ; Pamboukian, SV; Revilla-Martinez, M; Sanam, K; Tallaj, JA | 1 |
| Ando, K; Cao, X; Honda, A; Izumi-Nakaseko, H; Katagi, J; Nakamura, Y; Nomura, H; Ohara, H; Sugiyama, A; Wada, T | 1 |
| Ertl, G; Pauschinger, M; von Scheidt, W | 1 |
| Airan, B; Gulati, GS; Gupta, SK; Rajashekar, P; Talwar, S | 1 |
| Dupont Birkler, RI; Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Johannsen, M; Ravn, HB; Schmidt, MR; Støttrup, NB | 1 |
| Kalish, BT | 1 |
| Hattori, K; Hattori, Y; Matsuda, N; Palikhe, S; Sakai, M; Suzuki, T; Tomita, K; Yamashita, S; Yoshimura, N | 1 |
| Biskupiak, J; Bress, AP; King, JB; Munger, MA; Sainski-Nguyen, A; Shah, RU | 1 |
| Alaa, M; Leite, S; Leite-Moreira, AF; Lopes, L; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
| Gerds, TA; Jakobsen, CJ; Karaliunaite, Z; Nielsen, DV; Skals, RK; Torp-Pedersen, C | 1 |
| Baenziger, O; Balmer, C; Bettex, D; Buerki, C; Cannizzaro, V; Cavigelli-Brunner, A; Dave, H; Hug, MI | 1 |
| Apostolopoulou, SC; Kakava, F; Rammos, S; Tsoutsinos, A; Vagenakis, GA | 1 |
| Abu Elkassem, MS; Elmiligy, AE; Eskandr, AM; Hussein, L; Metwally, AA; Mourad, M; Sadik, SA | 1 |
| Schindler, E; Yamamoto, T | 1 |
| Aberle, C; Altshuler, D; Lewis, TC; Papadopoulos, J; Piper, GL | 1 |
| Barreto, HAG; Boergen-Lacerda, R; Sestren, B; Soares, LCDC | 1 |
| Dempsey, E; Rabe, H | 1 |
| Caballero, LG; Clausell, N; Domingues, FB; Goldraich, LA; Hastenteufel, LCT; Neyeloff, JL; Silva, ERRD | 1 |
| DiSanto, P; Hibbert, BM; Labinaz, M; Mathew, R; Ramirez, FD; Simard, T; Visintini, SM | 1 |
| Ariyoshi, N; Crossey, E; Devendra, G; Hamahata, N; Hasegawa, D; Ishihara, T; Nasu, M; Sato, R | 1 |
| Cheng, J; Kelly, J; Lupi, K; Malloy, R | 1 |
| de Waal, K; Phad, N | 1 |
| Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S | 1 |
| Ahn, C; Aronow, WS; Cooper, HA; Gass, AL; Gupta, CA; Khan, MH; Lanier, GM; Levine, A; Lloji, A; Mody, BP; Zaid, S | 1 |
| Wei, J; Ye, X; Yin, H; Zhang, R; Zhu, Y | 1 |
| Abdel-Razek, O; Almufleh, A; Bernick, J; Chan, V; Di Santo, P; Fernando, SM; Froeschl, M; Harnett, DT; Hibbert, B; Hutson, J; Jung, RG; Kyeremanteng, K; Labinaz, M; Le May, MR; Marbach, JA; Mathew, R; Merdad, A; Ramirez, FD; Russo, JJ; Simard, T; Wells, GA; Weng, W | 1 |
| Abdel-Razek, O; Bernick, J; Boczar, KE; D'Egidio, G; Di Santo, P; Dick, A; Glover, C; Hawken, S; Hibbert, B; Jung, RG; Mao, B; Marbach, JA; Mathew, R; McGuinty, C; Motazedian, P; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T; Skanes, S; So, DY; Wells, GA | 1 |
| Abdel-Razek, O; Di Santo, P; Dick, A; Fernando, SM; Froeschl, M; Gillmore, T; Glover, C; Hibbert, B; Jung, RG; Labinaz, M; Mao, B; Marbach, JA; Mathew, R; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T | 1 |
| Abdel-Razek, O; Bernick, J; Di Santo, P; Fu, A; Gillmore, T; Hibbert, B; Jung, RG; Labinaz, M; Lau, L; Mao, B; Marbach, JA; Mathew, R; Motazedian, P; Parlow, S; Russo, JJ; Simard, T; Theriault-Lauzier, P | 1 |
| Potter, BJ | 1 |
| Berra, L; Chang, MG; Gibson, LE | 1 |
| Di Santo, P; Hibbert, B; Mathew, R | 1 |
| Abdel-Razek, O; Di Santo, P; Fernando, SM; Froeschl, M; Hibbert, B; Jung, RG; Kapur, NK; Labinaz, M; Marbach, JA; Mathew, R; Parlow, S; Simard, T; Thayer, KL | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Pruc, M; Rafique, Z; Szarpak, L; Szwed, P | 1 |
| Bandyopadhyay, D; Biswas, S; Briasoulis, A; Fonarow, GC; Goel, A; Gupta, R; Lanier, GM; Malik, AH; Naidu, SS | 1 |
| Abdel-Razek, O; Di Santo, P; Froeschl, M; Fu, A; Hibbert, B; Hutson, J; Jung, RG; Malhotra, N; Mathew, R; Motazedian, P; Parlow, S; Prosperi-Porta, G; Ramirez, FD; Simard, T | 1 |
| Bader, I; Bergin, P; Dagan, M; Easton, K; Hare, JL; Kaye, DM; Lankaputhra, M; Leet, A; Linton, A; McLean, C; Patel, HC; Taylor, A; Tee, SL; Yeung, T | 1 |
| Albertson, TE; Chenoweth, JA; Lewis, JC; Morrissey, BM; Pugashetti, JV; Sandrock, CE | 1 |
| Acharya, P; Al-Masry, AA; Bajwa, S; Bakel, AV; Boda, I; Dalia, T; Goyal, A; Mastoris, I; Maurides, S; Noonan, G; Parimi, N; Sami, F; Sauer, A; Shah, Z; Tran, C | 1 |
| Abdel-Razek, O; Cheung, M; Di Santo, P; Fernando, SM; Hibbert, B; Hutson, JH; Jung, RG; Malhotra, N; Marbach, JA; Mathew, R; Motazedian, P; Nair, GM; Nery, PB; Parlow, S; Ramirez, FD; Russo, JJ; Simard, T; Thibert, MJ; Weng, W | 1 |
| Eaton, RE; Haas, GJ; Kissling, KT; McLaughlin, EM; Pickworth, KK | 1 |
| Ishii, T; Izawa, K; Kinoshita, M; Masuda, M; Onoda, T; Sato, N; Tanaka, H; Urano, A | 1 |
| Engoren, MC; Janda, AM; Kheterpal, S; Mathis, MR; Mentz, GB; Muehlschlegel, JD; Pagani, FD; Schonberger, RB; Shook, DC | 1 |
| Alkadri, J; Hu, R; Jeffers, MS; McDonald, B; McIsaac, DI; Ross, J | 1 |
| Billia, F; Brahmbhatt, DH; Fung, NL; Luis Scolari, F; Luk, A; Mihajlovic, V; Otsuki, M; Overgaard, CB; Rodenas-Alesina, E; Wang, VN | 1 |
| DE Pooter, F; Fils, JF; Havaux, R; Schmartz, D; VAN DER Linden, P; Willems, A | 1 |
| Fujita, T; Fukushima, N; Fukushima, S; Hada, T; Kainuma, S; Kamiya, H; Kunioka, S; Mochizuki, H; Seguchi, O; Shimojima, M; Tadokoro, N; Tsukamoto, Y; Watanabe, T | 1 |
| Chilson, K; Murray-Torres, RM; Sharma, A | 1 |
38 review(s) available for dobutamine and milrinone
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
Use of inotropes in the critical care setting.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Epinephrine; Humans; Imidazoles; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical | 1990 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
[Therapeutic options in cardiogenic shock].
Topics: Amrinone; Angioplasty, Balloon, Coronary; Assisted Circulation; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Humans; Milrinone; Myocardial Infarction; Nitroglycerin; Phosphodiesterase Inhibitors; Pyridones; Shock, Cardiogenic; Thrombolytic Therapy; Vasodilator Agents | 1995 |
Reversed ventilation-perfusion mismatch involving a pediatric patient in congestive heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Lung; Male; Milrinone; Pulmonary Circulation; Pulmonary Ventilation; Pyridones; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Ventilation-Perfusion Ratio | 1997 |
Hemodynamic support and the role of dopamine.
Topics: Acute Kidney Injury; Cardiac Output, Low; Cardiotonic Agents; Critical Care; Dobutamine; Dopamine; Epinephrine; Fluid Therapy; Hemodynamics; Humans; Isoproterenol; Milrinone; Norepinephrine; Phenylephrine; Pyridones; Renal Circulation; Renal Replacement Therapy; Vasoconstrictor Agents | 1998 |
Use of intravenous inotropic therapy in the home.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1998 |
Outpatient parenteral inotropic therapy for advanced heart failure.
Topics: Adrenergic beta-Agonists; Aged; Ambulatory Care; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome | 2000 |
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents | 2003 |
Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Topics: Adrenergic beta-Antagonists; Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Ethics, Clinical; Heart Failure; Humans; Milrinone; Myocardial Infarction; Nitroprusside; Quality of Life; Sympathomimetics; Vasodilator Agents | 2003 |
[Inotropic therapy in heart failure: general aspects and clinical results].
Topics: Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Heart Failure; Humans; Milrinone; Treatment Outcome | 2004 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
Diagnosis and treatment of neonatal hypotension outside the transitional period.
Topics: Adrenal Insufficiency; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Milrinone; Neonatology; Shock, Cardiogenic; Systemic Inflammatory Response Syndrome | 2005 |
Diagnosis and treatment of preterm transitional circulatory compromise.
Topics: Adrenal Cortex Hormones; Blood Circulation; Blood Pressure; Cardiac Output, Low; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Echocardiography; Epinephrine; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Milrinone; Risk Factors | 2005 |
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Syndrome | 2005 |
Classical inotropes and new cardiac enhancers.
Topics: Algorithms; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Hydrazones; Milrinone; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2007 |
[Combination therapy with PDE III inhibitor for heart failure].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2007 |
Therapy for acute heart failure syndromes.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome | 2009 |
Pulmonary arterial hypertension in human immunodeficiency virus infection.
Topics: Anti-Retroviral Agents; Causality; Comorbidity; Dobutamine; Drug Therapy, Combination; Endothelin Receptor Antagonists; HIV Infections; Humans; Hypertension, Pulmonary; Lung Transplantation; Milrinone; Phosphodiesterase Inhibitors; Prevalence; Prognosis; Prostaglandins; Respiration, Artificial; Survival Rate; Vasoconstrictor Agents | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
Topics: Cardiotonic Agents; Cardiovascular System; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Humans; Hydrazones; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Milrinone; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2012 |
[Combination therapy; dobutamine and milrinone].
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Milrinone; Myocardial Ischemia; Phosphodiesterase 3 Inhibitors | 2011 |
Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.
Topics: Cardiotonic Agents; Dobutamine; Hemodynamics; Humans; Intensive Care Units; Milrinone; Receptors, Adrenergic; Shock; Vasoconstrictor Agents | 2015 |
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality.
Topics: Bayes Theorem; Cardiac Surgical Procedures; Critical Illness; Dobutamine; Enoximone; Humans; Hydrazones; Milrinone; Pyridazines; Simendan; Vasodilator Agents | 2015 |
Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Heart Defects, Congenital; Humans; Hydrazones; Infant; Infant, Newborn; Milrinone; Postoperative Complications; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome; Time Factors | 2015 |
Long-term intravenous inotropes in low-output terminal heart failure?
Topics: Administration, Intravenous; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Drug Administration Schedule; Heart Failure; Heart Transplantation; Humans; Hydrazones; Milrinone; Odds Ratio; Practice Guidelines as Topic; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome; Waiting Lists | 2016 |
The Use of Cardiotonic Drugs in Neonates.
Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Intensive Care Units, Neonatal; Milrinone; Neonatal Sepsis; Norepinephrine; Persistent Fetal Circulation Syndrome; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2019 |
Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
Topics: Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Humans; Length of Stay; Milrinone; Randomized Controlled Trials as Topic | 2019 |
What Inotrope and Why?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Echocardiography; Epinephrine; Heart; Humans; Hypotension; Infant, Newborn; Lactic Acid; Milrinone; Norepinephrine; Perfusion Index; Skin; Spectroscopy, Near-Infrared; Ultrasonography; Urination; Vasopressins | 2020 |
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Network Meta-Analysis; Norepinephrine; Patient Safety; Recombinant Proteins; Shock, Cardiogenic; Simendan; Treatment Outcome | 2020 |
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone | 2022 |
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Cardiogenic | 2023 |
The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock.
Topics: Angiotensin II; Ascorbic Acid; Cardiotonic Agents; Catecholamines; Cytomegalovirus Infections; Dobutamine; Humans; Hydroxocobalamin; Methylene Blue; Milrinone; Shock; Shock, Septic; Thiamine; Vasoconstrictor Agents; Vasopressins | 2022 |
Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone | 2023 |
34 trial(s) available for dobutamine and milrinone
| Article | Year |
|---|---|
Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Topics: Adult; Aged; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Pyridones; Receptors, Adrenergic, beta; Stroke Volume; Time Factors | 1991 |
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Topics: Clinical Trials as Topic; Dobutamine; Ferricyanides; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Nitroprusside; Oxygen Consumption; Pyridones | 1986 |
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Nitroprusside; Norepinephrine; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilation | 1986 |
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1987 |
Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones; Systole | 1987 |
[The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Topics: Adult; Aged; Analysis of Variance; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroprusside; Phosphodiesterase Inhibitors; Pyridones | 1994 |
Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Myocardial Infarction; Pyridones; Treatment Outcome | 1996 |
[Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Topics: Aged; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroglycerin; Pyridones; Shock, Cardiogenic; Stroke Volume | 1996 |
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridones; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Thrombocytopenia; Treatment Outcome | 1997 |
The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha | 1999 |
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies | 2000 |
Comparison of systemic vasodilators: effects on flow in internal mammary and radial arteries.
Topics: Aged; Coronary Artery Bypass; Dobutamine; Female; Humans; Male; Mammary Arteries; Middle Aged; Milrinone; Nitroglycerin; Nitroprusside; Prospective Studies; Radial Artery; Regional Blood Flow; Sodium Chloride; Vasodilator Agents | 2001 |
Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
Topics: Adrenergic beta-Agonists; Blood Gas Analysis; Cardiac Output, Low; Cardiac Surgical Procedures; Dobutamine; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Hypotension; Male; Middle Aged; Milrinone; Postoperative Period | 2001 |
Milrinone echocardiographic viability test: a pilot study.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aged; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Echocardiography, Transesophageal; Female; Hemodynamics; Humans; Male; Milrinone; Myocardial Contraction; Myocardial Revascularization; Patient Selection; Phosphodiesterase Inhibitors; Pilot Projects; Predictive Value of Tests; Radionuclide Ventriculography; Recovery of Function; Stroke Volume; Thallium Radioisotopes; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Dopamine may preserve the myocardial oxygen balance better than dobutamine when administered with milrinone.
Topics: Aged; Cardiotonic Agents; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardium; Oxygen Consumption | 2002 |
Comparison of the cardiovascular effects of intracellular cyclic adenosine 3',5'-monophosphate (cAMP)-modulating agents in isoflurane-anesthetized cats.
Topics: Anesthetics; Animals; Blood Pressure; Bucladesine; Cardiotonic Agents; Cardiovascular System; Cats; Cyclic AMP; Dobutamine; Dopamine; Female; Heart Rate; Hemodynamics; Isoflurane; Male; Milrinone; Regional Blood Flow; Vasodilation | 2002 |
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Prospective Studies; Statistics as Topic | 2003 |
Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
Topics: Aged; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pilot Projects; Quality of Life; Time Factors | 2002 |
Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
Topics: Aged; Ambulatory Care; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hospice Care; Humans; Infusions, Intravenous; Male; Milrinone; Needs Assessment; New York; Palliative Care; Patient Acceptance of Health Care; Quality of Life; Terminally Ill | 2004 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine | 2006 |
Cardiovascular effects of a phosphodiesterase III inhibitor in the presence of carvedilol in dogs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Cardiovascular Physiological Phenomena; Carvedilol; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Dopamine; Drug Interactions; Female; Heart Rate; Male; Milrinone; Myocardial Contraction; Propanolamines | 2006 |
The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
Topics: Adrenergic beta-Agonists; Aged; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Elective Surgical Procedures; Female; Heart Diseases; Humans; Hydrazones; Intubation, Intratracheal; Length of Stay; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridazines; Simendan; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2007 |
Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
Topics: Adult; Aorta; Blood Pressure; Brachial Artery; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Female; Heart Ventricles; Heart-Assist Devices; Humans; Male; Middle Aged; Milrinone; Regional Blood Flow | 2007 |
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Milrinone therapy for enterovirus 71-induced pulmonary edema and/or neurogenic shock in children: a randomized controlled trial.
Topics: Cardiotonic Agents; Child, Preschool; Dobutamine; Dopamine; Enterovirus Infections; Female; Humans; Immunoglobulins; Infant; Infusions, Intravenous; Length of Stay; Male; Milrinone; Prospective Studies; Pulmonary Edema; Respiration, Artificial; Shock; Vietnam | 2013 |
Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind Randomized Clinical Pilot Study Comparing Dobutamine and Milrinone.
Topics: Adolescent; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Double-Blind Method; Female; Heart Defects, Congenital; Humans; Infant; Intensive Care Units, Pediatric; Male; Milrinone; Pilot Projects; Postoperative Period; Prospective Studies | 2018 |
Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
Topics: Adolescent; Adrenergic beta-1 Receptor Agonists; Adult; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Male; Middle Aged; Milrinone; Mitral Valve Stenosis; Nitroglycerin; Perioperative Care; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Vascular Resistance; Vasodilator Agents; Young Adult | 2018 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Comorbidity; Dobutamine; Double-Blind Method; Female; Hospital Mortality; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Shock, Cardiogenic | 2021 |
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Milrinone; Mortality; Outcome Assessment, Health Care; Shock, Cardiogenic | 2021 |
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Topics: Arterial Pressure; Cardiotonic Agents; Dobutamine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Topics: Dobutamine; Heart Arrest; Humans; Milrinone; Myocardial Infarction; Percutaneous Coronary Intervention; Shock, Cardiogenic; Stroke; Treatment Outcome | 2021 |
Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Topics: Dobutamine; Hospital Mortality; Humans; Lactic Acid; Milrinone; Shock, Cardiogenic | 2022 |
No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Topics: Dobutamine; Female; Heart Arrest; Humans; Male; Milrinone; Myocardial Infarction; Shock, Cardiogenic; Treatment Outcome | 2022 |
Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Topics: Arrhythmias, Cardiac; Dobutamine; Humans; Milrinone; Shock, Cardiogenic; Stroke Volume; Ventricular Function, Left | 2023 |
125 other study(ies) available for dobutamine and milrinone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Beneficial effect of MCI-154, a cardiotonic agent, on ischemic contractile failure and myocardial acidosis of dog hearts: comparison with dobutamine, milrinone and pimobendan.
Topics: Acidosis; Animals; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Male; Milrinone; Myocardial Contraction; Pyridazines; Pyridones | 1992 |
[Additive effects of milrinone and dobutamine in severe heart failure].
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones | 1992 |
Compared peripheral vascular responses to intravenous and intra-arterial administrations of positive inotropic agents in conscious dogs.
Topics: Acetylcholine; Animals; Blood Flow Velocity; Cardiotonic Agents; Dobutamine; Dogs; Female; Hemodynamics; Injections, Intra-Arterial; Injections, Intravenous; Male; Milrinone; Nitroglycerin; Norepinephrine; Ouabain; Piperazines; Pyridones; Vasoconstriction; Vasodilation; Vasomotor System | 1991 |
Improvement of postischemic contractile dysfunction of dog heart by MCI-154, a novel cardiotonic agent.
Topics: Adenosine Triphosphate; Animals; Calcium; Cardiotonic Agents; Coronary Disease; Dobutamine; Dogs; Female; Hemodynamics; Male; Milrinone; Myocardial Contraction; Myocardium; Pyridazines; Pyridones; Ventricular Function, Left | 1991 |
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pyridones | 1991 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine.
Topics: Animals; Dobutamine; Dogs; Dopamine; Hypertension, Pulmonary; Milrinone; Pulmonary Circulation; Pulmonary Embolism; Pyridones; Vasodilation; Vasodilator Agents | 1990 |
Reduced positive inotropic effects in diseased human ventricular myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Aged; Calcium; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Diseases; Histamine; Humans; Isoproterenol; Male; Middle Aged; Milrinone; Myocardial Contraction; Myocardium; Pyridones; Stimulation, Chemical; Theophylline | 1986 |
Central and regional vascular hemodynamics following intravenous milrinone in the conscious rat: comparison with dobutamine.
Topics: Animals; Consciousness; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Injections, Intravenous; Milrinone; Pyridones; Rats; Regional Blood Flow | 1987 |
Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Hemodynamics; Male; Milrinone; Pyridones; Regional Blood Flow; Vasodilator Agents | 1987 |
In vitro method for measurement of cardiac performance and responses to inotropic drugs after experimentally induced myocardial infarction in the rat.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Myocardial Infarction; Perfusion; Pyridones; Rats; Rats, Inbred Strains | 1989 |
Cardiac and hemodynamic profile of the new cardiotonic agent, DPI 201-106, in the conscious dog.
Topics: Animals; Autonomic Nervous System; Cardiotonic Agents; Dobutamine; Dogs; Drug Interactions; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Piperazines; Pyridones | 1989 |
Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Topics: Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta | 1988 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Chronic Disease; Death, Sudden; Dobutamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1988 |
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Topics: Coronary Circulation; Coronary Vessels; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
New positive inotropic drugs for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents | 1985 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
Assessment of left ventricular end-systolic pressure-volume relations with an impedance catheter and transient inferior vena cava occlusion: use of this system in the evaluation of the cardiotonic effects of dobutamine, milrinone, Posicor and epinephrine.
Topics: Animals; Blood Pressure; Cardiography, Impedance; Cardiotonic Agents; Constriction; Dobutamine; Dogs; Drug Evaluation, Preclinical; Epinephrine; Heart Rate; Milrinone; Myocardial Contraction; Pyridones; Quinazolines; Stroke Volume; Swine; Vena Cava, Inferior | 1986 |
Milrinone versus dobutamine: contribution of altered myocardial mechanics and augmented inotropic state to improved left ventricular performance.
Topics: Adult; Cardiotonic Agents; Dobutamine; Heart; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Pyridones; Time Factors | 1986 |
Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Topics: Aged; Coronary Circulation; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardium; Pyridones | 1986 |
Short-term use of intravenous milrinone for heart failure.
Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Diastole; Dobutamine; Electrocardiography; Heart Rate; Humans; Injections, Intravenous; Milrinone; Myocardial Contraction; Pyridones; Time Factors; Vasodilator Agents | 1995 |
Pharmacologic support with high-energy phosphate preservation in the postischemic neonatal heart.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Animals, Newborn; Cardiotonic Agents; Cyclic AMP; Dobutamine; Drug Evaluation, Preclinical; Heart Defects, Congenital; Hemodynamics; Humans; In Vitro Techniques; Infant, Newborn; Milrinone; Myocardial Ischemia; Myocardial Reperfusion; Pyridones; Rabbits | 1995 |
Comparison of positive inotropic effects of milrinone, dobutamine and ouabain.
Topics: Animals; Cardiotonic Agents; Culture Techniques; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Milrinone; Models, Cardiovascular; Myocardial Contraction; Ouabain; Papillary Muscles; Pyridones; Rabbits | 1994 |
Repletion of high energy phosphates in the postischemic neonatal heart.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dobutamine; Heart; Milrinone; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nucleotides; Phosphodiesterase Inhibitors; Purines; Pyridones; Rabbits; Time Factors; Ventricular Function | 1996 |
Milrinone in patients awaiting heart transplantation.
Topics: Cardiotonic Agents; Dobutamine; Drug Costs; Heart Transplantation; Humans; Milrinone; Pyridones | 1996 |
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Topics: Ambulatory Care; Amrinone; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Milrinone; Patient Admission; Patient Education as Topic; Pyridones; Time Factors | 1996 |
Effects of a novel inotropic agent, BAY y 5959, in conscious dogs: comparison with dobutamine and milrinone.
Topics: Animals; Cardiac Output; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Female; Hemodynamics; Male; Milrinone; Oxygen Consumption; Pyridones; Ventricular Function, Left | 1997 |
The effect of positive inotropes on the failing human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 1997 |
[Current views on Milrinon--a PDE-III-inhibitor].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Humans; Milrinone; Oxygen Consumption; Pyridones | 1994 |
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Topics: Cardiotonic Agents; Cause of Death; Costs and Cost Analysis; Direct Service Costs; Dobutamine; Female; Heart Failure; Home Care Services; Humans; Length of Stay; Male; Middle Aged; Milrinone; Pyridones; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome | 1997 |
Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
Topics: Aged; Aged, 80 and over; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Monitoring, Physiologic; Observer Variation; Oxygen; Pyridones; Retrospective Studies; Thermodilution; Tricuspid Valve Insufficiency | 1998 |
Effects of concomitant usage of milrinone and catecholamine for weaning from cardiopulmonary bypass.
Topics: Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors | 1998 |
Effects of phosphodiesterase inhibitors after coronary artery bypass grafting.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Hypotension; Imidazoles; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Postoperative Period; Pyridones; Vasodilator Agents | 1999 |
[Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Cardiomyopathy, Dilated; Dobutamine; Dopamine; Fentanyl; Heart Valve Prosthesis Implantation; Humans; Intra-Aortic Balloon Pumping; Male; Milrinone; Mitral Valve; Mitral Valve Stenosis; Perioperative Care | 1999 |
Intermittent inotropes for advanced heart failure: inquiring minds want to know.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Treatment Outcome | 1999 |
Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure.
Topics: Animals; Calcium-Transporting ATPases; Cardiac Output, Low; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Echocardiography; Female; Hemodynamics; Male; Milrinone; Myocardial Contraction; Myocardium; Ventricular Function, Left | 2000 |
Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Hemodynamics; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Rolipram; Sarcoplasmic Reticulum; Ventricular Function, Left | 2000 |
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans; Length of Stay; Male; Middle Aged; Milrinone; Nitroglycerin; Nitroprusside; Retrospective Studies; Treatment Outcome; United States | 2001 |
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2001 |
Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Monitoring, Physiologic; Patient Selection; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Amyloidosis; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Male; Middle Aged; Milrinone; Norepinephrine; Peritoneal Dialysis; Phenylephrine; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 2002 |
A bridge for the 21st century in heart transplantation?
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Heart Transplantation; Humans; Milrinone; Prospective Studies; Randomized Controlled Trials as Topic | 2003 |
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
Topics: Adult; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Electric Countershock; Female; Heart Failure; Heart Transplantation; Home Care Services; Humans; Male; Middle Aged; Milrinone; Outcome Assessment, Health Care; Retrospective Studies; Severity of Illness Index; Waiting Lists | 2003 |
Sustained use of nesiritide to aid in bridging to heart transplant.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Preoperative Care; Time Factors; Treatment Outcome; Waiting Lists | 2003 |
Dobutamine-related asthma in a patient awaiting cardiac transplantation: the eosinophilic dilemma.
Topics: Asthma; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Eosinophilia; Heart Transplantation; Humans; Male; Middle Aged; Milrinone | 2004 |
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Topics: Adult; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Dopamine; Empirical Research; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Longitudinal Studies; Male; Middle Aged; Milrinone; Survival Rate; Waiting Lists | 2004 |
Effects of dopamine, dobutamine, amrinone and milrinone on regional blood flow in isoflurane anesthetized dogs.
Topics: Amrinone; Animals; Blood Pressure; Brain; Cardiotonic Agents; Catecholamines; Coronary Circulation; Digestive System; Dobutamine; Dogs; Dopamine; Eye; Isoflurane; Lung; Microspheres; Milrinone; Muscle, Skeletal; Phosphodiesterase Inhibitors; Regional Blood Flow | 2004 |
Dobutamine versus milrinone after subarachnoid hemorrhage.
Topics: Adrenergic beta-Agonists; Adult; Dobutamine; Female; Humans; Male; Middle Aged; Milrinone; Myocardial Stunning; Phosphodiesterase Inhibitors; Subarachnoid Hemorrhage | 2005 |
Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Dobutamine; Dogs; Female; Gastric Mucosa; Hemodynamics; Hydrazones; Male; Microcirculation; Milrinone; Oxygen; Pyridazines; Simendan; Treatment Outcome; Vasodilator Agents | 2005 |
Levosimendan and gut mucosal blood flow--not all inotropes are created equal.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Gastric Mucosa; Hemoglobinometry; Hydrazones; Microcirculation; Milrinone; Oxygen Consumption; Pyridazines; Simendan; Vasodilator Agents | 2005 |
Effects of neonatal hypoxia in the rat on inotropic stimulation of the adult heart.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Body Weight; Cardiotonic Agents; Dobutamine; Heart Rate; Hypoxia; Isoproterenol; Male; Milrinone; Myocardium; Organ Size; Rats; Rats, Sprague-Dawley; Signal Transduction; Ventricular Function, Left | 2005 |
Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support.
Topics: Blood Flow Velocity; Brachial Artery; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Follow-Up Studies; Forearm; Heart Failure; Humans; Injections, Intravenous; Isometric Contraction; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler; Vasoconstriction; Ventricular Function, Right | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Health Care Costs; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Regression Analysis; Retrospective Studies; Treatment Outcome | 2006 |
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response Relationship, Drug; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Muscular Dystrophy, Duchenne; Palliative Care; Quality of Life; Time Factors | 2006 |
Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiac Output; Cardiotonic Agents; Coronary Stenosis; Dobutamine; Drug Administration Schedule; Heart Rate; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Swine; Vascular Resistance; Ventricular Dysfunction, Left | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine | 2006 |
Chronic inotropic therapy in end-stage heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Costs; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Medicare; Middle Aged; Milrinone; Severity of Illness Index; Time Factors | 2006 |
Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
Topics: Adrenergic beta-Agonists; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Humans; Hydrazones; Milrinone; Myocardial Contraction; Perioperative Care; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2007 |
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Dobutamine; Heart Failure; Hydrazones; Lipopolysaccharides; Milrinone; Pyridazines; Rabbits; Sepsis; Simendan; Systole; Ventricular Function, Left | 2007 |
The cardiovascular effects of adrenaline, dobutamine and milrinone in rabbits using pressure-volume loops and guinea pig isolated atrial tissue.
Topics: Adrenergic Agonists; Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Guinea Pigs; Heart; Heart Atria; Heart Rate; Male; Milrinone; Myocardial Contraction; Organ Culture Techniques; Rabbits; Vascular Resistance | 2007 |
Home inotropic therapy in children.
Topics: Adolescent; Cardiotonic Agents; Child; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome; Waiting Lists | 2007 |
Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease.
Topics: Cardiotonic Agents; Dobutamine; Female; Fontan Procedure; Heart Bypass, Right; Heart Defects, Congenital; Heart Ventricles; Humans; Infant; Length of Stay; Male; Milrinone; Multivariate Analysis; Natriuretic Peptide, Brain; Palliative Care; Postoperative Period; Prognosis; Prospective Studies | 2008 |
Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
Topics: Acetamides; Animals; Blood Pressure; Calcium; Cardiac Output; Cardiotonic Agents; Cardiovascular System; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hydrazones; Male; Milrinone; Myocardial Contraction; Oxygen Consumption; Potassium; Potassium Channels; Pulmonary Circulation; Pyridazines; Simendan; Time Factors; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 2008 |
Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and m
Topics: Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Cardiovascular Physiological Phenomena; Dobutamine; Drug Combinations; Heart Rate; Hemodynamics; Hydrazones; Male; Milrinone; Myocardial Contraction; Pyridazines; Rats; Rats, Sprague-Dawley; Simendan; Vascular Resistance | 2008 |
Sympathomimetic inefficiency in restoring contractility in the acute or chronic beta-blocker-treated ischaemic heart: comparison with a new agent.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Dogs; Etiocholanolone; Male; Milrinone; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Sodium-Potassium-Exchanging ATPase; Sympathomimetics; Time Factors; Treatment Failure; Ventricular Dysfunction, Left | 2008 |
Anti-ischemic effects of inotropic agents in experimental right ventricular infarction.
Topics: Animals; Blood Gas Analysis; Cardiotonic Agents; Dobutamine; Female; Heart Ventricles; Hemodynamics; Hydrazones; Inflammation Mediators; Milrinone; Myocardial Infarction; Myocardial Ischemia; Myocarditis; Myocardium; Myoglobin; Neutrophil Infiltration; Pyridazines; Simendan; Swine; Troponin T | 2009 |
Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB).
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Drug Utilization Review; Epinephrine; Female; Heart Valve Prosthesis Implantation; Humans; Intraoperative Care; Kidney Failure, Chronic; Male; Milrinone; Norepinephrine; Predictive Value of Tests; Retrospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Sympathomimetics; Ventricular Function, Left | 2009 |
Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
Topics: Animals; Calcium; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hydrazones; Hypothermia; In Vitro Techniques; Milrinone; Myocardial Contraction; Pyridazines; Random Allocation; Simendan; Temperature | 2009 |
[Anesthetic management for emergency laparotomy in an adult patient with Eisenmenger syndrome: a case report].
Topics: Anesthesia, General; Cardiotonic Agents; Dobutamine; Eisenmenger Complex; Emergencies; Female; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Intraoperative Care; Intraoperative Complications; Laparotomy; Middle Aged; Milrinone; Monitoring, Intraoperative; Norepinephrine; Vasoconstrictor Agents | 2009 |
The efficacy of intravenous milrinone in left ventricular restoration.
Topics: Aged; Cardiac Surgical Procedures; Cardiomyopathies; Cardiopulmonary Bypass; Cardiotonic Agents; Combined Modality Therapy; Dobutamine; Epinephrine; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Myocardial Ischemia; Phosphodiesterase Inhibitors; Recovery of Function; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2009 |
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Topics: Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Should we use outpatient dobutamine or milrinone?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Injections, Intravenous; Milrinone; Outpatients; Treatment Outcome | 2009 |
Milrinone, dobutamine or epinephrine use in asphyxiated newborn pigs resuscitated with 100% oxygen.
Topics: Animals; Animals, Newborn; Bronchodilator Agents; Cardiotonic Agents; Dobutamine; Epinephrine; Female; Hypoxia; Male; Milrinone; Oxygen; Random Allocation; Resuscitation; Swine | 2010 |
Rotating inotrope therapy in a pediatric population with decompensated heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Milrinone; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome | 2011 |
Hospital in the home.
Topics: Australia; Cardiotonic Agents; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Milrinone; Palliative Care | 2011 |
Prevention for pediatric low cardiac output syndrome: results from the European survey EuLoCOS-Paed.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child, Preschool; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Europe; Health Care Surveys; Hospitals; Humans; Hydrazones; Infant; Milrinone; Pediatrics; Practice Patterns, Physicians'; Pyridazines; Simendan; Surveys and Questionnaires | 2011 |
Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS-Paed survey.
Topics: Algorithms; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Dobutamine; Dopamine; Drug Therapy, Combination; Drug Utilization; Epinephrine; Europe; Health Care Surveys; Humans; Milrinone; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vascular Resistance | 2011 |
Vassopressors and inotropes.
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Milrinone; Norepinephrine; Phenylephrine; Vasoconstrictor Agents; Vasopressins | 2011 |
[Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Topics: Acute Disease; Adolescent; Cardiotonic Agents; Child, Preschool; Dobutamine; Heart Failure; Humans; Hydrazones; Male; Milrinone; Pyridazines; Simendan | 2011 |
Pharmacologic interventions to improve splanchnic oxygenation during ventilation with positive end-expiratory pressure.
Topics: Anesthesia, Epidural; Dobutamine; Dopamine; Humans; Hydrazones; Milrinone; Oxygen; Oxygen Consumption; Oxyhemoglobins; Positive-Pressure Respiration; Pulmonary Ventilation; Pyridazines; Receptors, Catecholamine; Simendan; Splanchnic Circulation; Vital Capacity | 2012 |
Neurogenic stunned myocardium after embolization in two children with vein of Galen aneurysmal malformation.
Topics: Cardiotonic Agents; Cerebral Angiography; Diagnosis, Differential; Dobutamine; Humans; Infant, Newborn; Intracranial Aneurysm; Male; Milrinone; Myocardial Stunning; Treatment Outcome; Vein of Galen Malformations | 2013 |
Metabolic effects of three different inotropic strategies in the newborn piglet myocardium.
Topics: Animals; Animals, Newborn; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Lactic Acid; Microdialysis; Milrinone; Myocardium; Pyruvic Acid; Swine | 2013 |
Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era.
Topics: Biopsy; Dobutamine; Eosinophils; Heart Failure; Heart Transplantation; Humans; Milrinone; Myocarditis; Myocardium; Prognosis; Retrospective Studies; Survival Analysis; Survival Rate | 2013 |
Levosimendan: a retrospective single-center case series.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Male; Milrinone; Norepinephrine; Pyridazines; Retrospective Studies; Simendan; Sympathomimetics; Treatment Outcome | 2013 |
Inotropic therapy for right ventricular failure in newborn piglets: effect on contractility, hemodynamics, and interventricular interaction.
Topics: Animals; Animals, Newborn; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dopamine; Epinephrine; Milrinone; Stroke Volume; Swine; Vascular Resistance; Ventricular Dysfunction, Right | 2014 |
Safety of Enteral Feedings in Critically Ill Children Receiving Vasoactive Agents.
Topics: Adolescent; Cardiovascular Agents; Child; Child, Preschool; Critical Illness; Dobutamine; Dopamine; Enteral Nutrition; Epinephrine; Female; Gastrointestinal Tract; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Logistic Models; Male; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2016 |
Compatibility of conivaptan injection with select cardiovascular medications.
Topics: Benzazepines; Cardiovascular Agents; Contraindications; Dobutamine; Dopamine; Drug Combinations; Drug Incompatibility; Humans; Infusions, Intravenous; Milrinone; Nitroglycerin | 2014 |
Sepsis, venous return, and teleology.
Topics: Algorithms; Blood Pressure; Cardiac Output; Coronary Circulation; Critical Illness; Dihydroergotamine; Dobutamine; Heart Rate; Hemodynamics; Humans; Milrinone; Models, Cardiovascular; Norepinephrine; Propanolamines; Shock, Septic; Tilt-Table Test; Vascular Resistance | 2014 |
Management of catecholamine-induced stunned myocardium--a case report.
Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Fluid Therapy; Heart Failure; Humans; Intraoperative Complications; Middle Aged; Milrinone; Myocardial Stunning; Neurosurgical Procedures; Norepinephrine; Subarachnoid Hemorrhage; Vasodilator Agents | 2015 |
Effects of various cardiovascular drugs on indices obtained with two-dimensional speckle tracking echocardiography of the left atrium and time-left atrial area curve analysis in healthy dogs.
Topics: Animals; Area Under Curve; Atrial Function, Left; Cardiovascular Agents; Dobutamine; Dogs; Echocardiography; Female; Male; Milrinone; Phenylephrine; Propanolamines | 2015 |
Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
Topics: Administration, Intravenous; Adult; Aged; Alabama; Atrial Fibrillation; Bacteremia; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Arrest; Heart Conduction System; Heart Failure; Home Care Services; Hospitals, University; Humans; Male; Middle Aged; Milrinone; Pacemaker, Artificial; Patient Readmission; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome | 2016 |
Effects of a prostagrandin EP4-receptor agonist ONO-AE1-329 on the left ventricular pressure-volume relationship in the halothane-anesthetized dogs.
Topics: Anesthetics, Inhalation; Animals; Blood Pressure; Cardiac Output; Dobutamine; Dogs; Dopamine; Female; Halothane; Heart Rate; Methyl Ethers; Milrinone; Receptors, Prostaglandin E, EP4 Subtype; Stroke Volume; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 2016 |
Crossed Pulmonary Arteries in a Patient With Persistent Truncus Arteriosus.
Topics: Abnormalities, Multiple; Anastomosis, Surgical; Cardiomegaly; Cardiopulmonary Bypass; Combined Modality Therapy; Dobutamine; Female; Humans; Hypertension, Pulmonary; Infant; Milrinone; Pulmonary Artery; Sildenafil Citrate; Truncus Arteriosus, Persistent; Vascular Surgical Procedures | 2016 |
Citric Acid Cycle Metabolites Predict the Severity of Myocardial Stunning and Mortality in Newborn Pigs.
Topics: Animals; Biomarkers; Cardiotonic Agents; Chromatography, Liquid; Citric Acid Cycle; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Microdialysis; Milrinone; Myocardial Stunning; Random Allocation; Severity of Illness Index; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Swine; Tandem Mass Spectrometry; Treatment Outcome | 2016 |
Management of Neonatal Hypotension.
Topics: Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Ductus Arteriosus, Patent; Humans; Hypotension; Infant, Newborn; Long Term Adverse Effects; Milrinone; Shock, Septic | 2017 |
Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.
Topics: Adenylyl Cyclases; Animals; Cardiotonic Agents; Cecum; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Disease Models, Animal; Dobutamine; GTP-Binding Protein alpha Subunits, Gs; Hydrolysis; Inflammation Mediators; Ligation; Male; Mice, Inbred BALB C; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase 3 Inhibitors; Punctures; Receptors, Adrenergic, beta-1; Sepsis; Signal Transduction; Up-Regulation | 2017 |
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Milrinone; Mortality; Retrospective Studies | 2017 |
Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.
Topics: Animals; Calcium; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Hydrazones; Hypertension, Pulmonary; Male; Milrinone; Pyridazines; Rats; Rats, Wistar; Simendan | 2017 |
Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Topics: Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cardiotonic Agents; Cohort Studies; Denmark; Dobutamine; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Milrinone; Prospective Studies; Retrospective Studies | 2018 |
Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Topics: Adolescent; Adult; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Infant; Infusions, Intravenous; Male; Milrinone; Retrospective Studies; Simendan; Survival Rate; Treatment Outcome; Young Adult | 2018 |
New Drugs for Old Problems: Which Inotropes for Critically Ill Children?
Topics: Cardiac Output, Low; Child; Critical Illness; Dobutamine; Double-Blind Method; Humans; Milrinone; Pilot Projects | 2018 |
Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Topics: Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2019 |
Standard concentration infusions of inotropic and vasoactive drugs in paediatric intensive care: a strategy for patient safety.
Topics: Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Dopamine; Epinephrine; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Pediatric; Maximum Allowable Concentration; Milrinone; Patient Safety; Retrospective Studies; Risk Assessment; Vasoconstrictor Agents; Vasodilator Agents | 2019 |
Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.
Topics: Adult; Aged; Cardiotonic Agents; Clinical Protocols; Critical Care; Dobutamine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Milrinone; Patient Discharge; Retrospective Studies; Treatment Outcome | 2019 |
Effects of Inotropes on the Mortality in Patients With Septic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Hospital Mortality; Humans; Milrinone; Retrospective Studies; Shock, Septic | 2021 |
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Milrinone; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Outpatients; Retrospective Studies | 2020 |
The effect of dobutamine vs milrinone in sepsis: A big data, real-world study.
Topics: Big Data; Cardiotonic Agents; Dobutamine; Humans; Milrinone; Retrospective Studies; Sepsis | 2021 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
Topics: Cardiotonic Agents; Dobutamine; Epinephrine; Humans; Milrinone; Shock, Cardiogenic | 2021 |
Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine.
Topics: Adult; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Milrinone; Myocardium | 2022 |
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Topics: Adrenergic beta-Antagonists; Adult; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies | 2022 |
Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
[Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock].
Topics: Dobutamine; Humans; Milrinone; Norepinephrine; Pharmaceutical Preparations; Shock, Cardiogenic | 2022 |
Patient-, Clinician-, and Institution-level Variation in Inotrope Use for Cardiac Surgery: A Multicenter Observational Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Female; Humans; Intraoperative Care; Male; Middle Aged; Milrinone; Myocardial Contraction | 2023 |
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2023 |
The choice of perioperative inotropic support impacts the outcome of small infants undergoing complex cardiac surgery: an observational study.
Topics: Cardiac Surgical Procedures; Child; Child, Preschool; Dobutamine; Epinephrine; Hospital Mortality; Humans; Infant; Milrinone | 2023 |
Successful echocardiography-guided medical management of severe early post-implant right ventricular failure in a patient with left ventricular assist device support: a case report.
Topics: Adolescent; Dobutamine; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Milrinone; Retrospective Studies | 2023 |
Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt.
Topics: Anesthesia, General; Anesthetics; Child; Dobutamine; Epinephrine; Humans; Hypertension, Pulmonary; Infant; Milrinone; Norepinephrine; Retrospective Studies; Vasopressins | 2024 |